The Catalyst Group Company Profile

15:33 EDT 18th March 2018 | BioPortfolio

The Catalyst Group (TCG) is one of theworld's leading chemical consulting firms
dedicated to the polymer and elastomer,
petrochemical and refining, specialty and
fine chemicals and pharmaceuticals, and
process technology industries. With headquarters in Spring House, Pennsylvania
(a suburb of Philadelphia), The Catalyst
Group has representatives in United
Kingdom, Europe, Japan, and Southeast


750 N. Bethlehem Pike
Lower Gwynedd
United States of America


Phone: 215-628-4447
Fax: 215-628-2267

News Articles [707 Associated News Articles listed on BioPortfolio]

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Your NEJM Group Today: NEJM Catalyst Live Event on Integrated Care / MD Denial of Patient Requests / Alaska Rheumatology Opportunity

Take a look at today's offering from NEJM Group: NEJM Catalyst: Live Web Event: Innovative leaders and researchers will examine how society can redefine health...

Your NEJM Group Today: Fair Pharma? / Guidelines on Mild Cognitive Impairment / New Mexico Pulmonology Opportunity

Check out some of the highlights from NEJM Group: NEJM Catalyst: Interview: Intermountain's CEO discusses their new drug company. "What we aim to do is...

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Catalyst eyes 2018 filing for rare disease drug candidate

Positive data from a second Phase 3 study has Catalyst on track to resubmit Firdapse for potential U.S. approval.

Your NEJM Group Today: Late-Career Switch to Telemedicine / Meds for HF with Preserved Ejection Fraction? / South Carolina Internist Opportunity

Take a look at today's offering from NEJM Group: NEJM Catalyst: Article: Instead of retiring, a physician in his 70s pursued a fellowship in telehealth...

10 SU2C Catalyst® collaborative clinical trial projects combine treatments from 9 pharma

(Entertainment Industry Foundation) 10 SU2C Catalyst® clinical trial projects awarded, collaborating across academic /industry borders, and correlated translational research will deepen understanding...

Your NEJM Group Today: Tiered Escalation Huddles / Encouraging Teens to Diet & Long-Term Effects / Maryland Internal Medicine Opportunity

Take a look at today's offering from NEJM Group: NEJM Catalyst: In 15 minutes each day, this model helps leaders discover and resolve needs of...

PubMed Articles [2320 Associated PubMed Articles listed on BioPortfolio]

Resolving a Reactive Organometallic Intermediate from Dynamic Directing Group Systems by Selective C-H Activation.

Catalyst discovery from systems of potential precursors is a challenging endeavor. Herein, a new strategy applying dynamic chemistry to the identification of catalyst precursors from C-H activation of...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

Copper catalyzed oxidative homocoupling of terminal alkynes to 1,3-diynes: a Cu3(BTC)2 MOF as an efficient and ligand free catalyst for Glaser-Hay coupling.

A straightforward and efficient method has been demonstrated for the oxidative coupling of terminal alkynes using a simple Cu3(BTC)2-metal organic framework as a sustainable heterogeneous copper catal...

A solid iridium catalyst for diastereoselective hydrogenation.

An Ir(NHC) supported catalyst is used in the selective hydrogenation of terpinen-4-ol to cis p-menthan-4-ol. Its activity, selectivity and stability are compared to those of a homogeneous homologue [I...

Plasma-catalyst hybrid reactor with CeO2/γ-Al2O3 for benzene decomposition with synergetic effect and nano particle by-product reduction.

A dielectric barrier discharge (DBD) catalyst hybrid reactor with CeO2/γ-Al2O3 catalyst balls was investigated for benzene decomposition at atmospheric pressure and 30 °C. At an energy density of ...

Clinical Trials [3524 Associated Clinical Trials listed on BioPortfolio]

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Companies [1698 Associated Companies listed on BioPortfolio]

The Catalyst Group

The Catalyst Group (TCG) is one of theworld's leading chemical consulting firmsdedicated to the polymer and elastomer,petrochemical and refining, specialty andfine chemicals and pharmaceuticals, andpr...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Catalyst Advisors, L.P.

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate cr...

More Information about "The Catalyst Group" on BioPortfolio

We have published hundreds of The Catalyst Group news stories on BioPortfolio along with dozens of The Catalyst Group Clinical Trials and PubMed Articles about The Catalyst Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Catalyst Group Companies in our database. You can also find out about relevant The Catalyst Group Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record